Tag: chronic limb-threatening ischaemia

BEST-CLI

Late-breaking analysis set to expose the ‘why and how’ of endovascular...

Set to be presented at the upcoming Society of Interventional Radiology (SIR) annual scientific meeting (23–28 March, Salt Lake City, USA), an anticipated late-breaking...

Inari Medical completes LimFlow acquisition for CLTI treatment

Inari Medical has announced that it has completed its acquisition of chronic limb-threatening ischaemia (CLTI) treatment maker LimFlow. The Irvine, California–based company earlier this month...
agreement

LimFlow announces agreement to be acquired by Inari Medical

LimFlow announced today that it has entered into a definitive agreement to be acquired by Inari Medical. A press release details that, under the terms...
MOTIV

“Excellent” 24-month MOTIV BTK outcomes for bioresorbable scaffold use in below-the-knee...

Presenting data from the MOTIV bioresorbable scaffold (Reva Medical) below-the-knee (BTK) trial during Saturday’s FIRST@CIRSE session at this year’s Cardiovascular and Interventional Radiological Society...

12-month PRISTINE registry data show efficacy of sirolimus-eluting balloon in the...

Tze Tec Chong (Singapore General Hospital, Singapore) presented results from the PRISTINE registry at this year’s Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023...
SCAI

Insights from largest chronic limb-threatening ischaemia study to inform quality of...

Data from a cohort of one million patients with chronic limb-threatening ischaemia (CLTI) were recently presented as late-breaking clinical research at the Society for Cardiovascular...
CLTI

New analysis of chronic limb-threatening ischaemia patients places BEST-CLI trial into...

A new analysis of chronic limb-threatening ischaemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography &...

BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients

A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...

CX 2023 highlight: The BASIL-2 trial

Data and discussion on revascularisation treatment strategies for patients with chronic limb-threatening ischaemia (CLTI) will take centre stage at the CX 2023 Consensus update,...

First data from BEST-CLI bring surgical bypass into the forefront of...

The first results from the BEST-CLI randomised controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV)...

Physicians call for clinical application of “helpful, meaningful” AMPREDICT decision support...

Researchers have found that the AMPREDICT decision support tool (DST) demonstrates “strong usability characteristics and clinical relevance” in amputation level decision making for patients...
soundbite

SoundBite Medical announces use of its Active Wire 0.014″ platform at...

SoundBite Medical Solutions recently announced the use of its novel Active Wire 0.014” platform at a first site in the USA in the successful...

XO Score scoring sheath platform wins medical design award

Transit Scientific today announced that its XO Score scoring sheath platform has been named a winner in the 2021 Medical Design Excellence Awards (MDEA)....

Micro Medical Solutions receives FDA breakthrough device designation for MicroStent vascular...

Micro Medical Solutions (MMS) recently announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its MicroStent vascular stent....
journal

The CLI Global Society announces the Journal of Critical Limb Ischemia

The CLI Global Society is launching the first peer-reviewed academic journal focusing on interventional techniques pertaining to critical limb ischemia (CLI). The new journal,...

Systematic review and meta-analysis finds “substantial” one-year mortality rate in octogenarians...

In octogenarians with chronic limb-threatening ischaemia (CLTI), researchers found a one-year mortality rate of 32% after revascularisation, which was significantly higher than in non-octogenarians....